Thomas William Burns - Dec 15, 2022 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Role
CHAIRMAN & CEO, Director
Signature
Diana Scherer, Attorney-in-Fact
Stock symbol
GKOS
Transactions as of
Dec 15, 2022
Transactions value $
$0
Form type
4
Date filed
12/19/2022, 06:45 PM
Previous filing
Dec 5, 2022
Next filing
Jan 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Award $0 +10.4K +1.55% $0.00 685K Dec 15, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Award $0 +21K $0.00 21K Dec 15, 2022 Common Stock 21K $55.18 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 70% of the number of shares of common stock reported herein will vest and be delivered in January 2023, and the remaining 30% will vest and be delivered in March 2023.
F2 Includes 91,279 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F4 70% of the portion of the option reported herein will vest and become exercisable in January 2023, and the remaining 30% will vest and become exercisable in March 2023.